These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 20403082

  • 41. Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release.
    Ago Y, Tanaka T, Kita Y, Tokumoto H, Takuma K, Matsuda T.
    Neuropharmacology; 2012 Mar; 62(4):1634-9. PubMed ID: 22001792
    [Abstract] [Full Text] [Related]

  • 42. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.
    Linnér L, Endersz H, Ohman D, Bengtsson F, Schalling M, Svensson TH.
    J Pharmacol Exp Ther; 2001 May; 297(2):540-6. PubMed ID: 11303041
    [Abstract] [Full Text] [Related]

  • 43. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
    Kodama T, Kojima T, Honda Y, Hosokawa T, Tsutsui KI, Watanabe M.
    J Neurosci; 2017 Mar 01; 37(9):2387-2394. PubMed ID: 28154152
    [Abstract] [Full Text] [Related]

  • 44. Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism.
    Hara Y, Ago Y, Taruta A, Katashiba K, Hasebe S, Takano E, Onaka Y, Hashimoto H, Matsuda T, Takuma K.
    Autism Res; 2016 Sep 01; 9(9):926-39. PubMed ID: 26714434
    [Abstract] [Full Text] [Related]

  • 45. Effect of beta-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex.
    Murata M, Katagiri N, Ishida K, Abe K, Ishikawa M, Utsunomiya I, Hoshi K, Miyamoto K, Taguchi K.
    Brain Res; 2009 May 07; 1269():40-6. PubMed ID: 19285043
    [Abstract] [Full Text] [Related]

  • 46. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
    Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D, Atomoxetine/Methylphenidate Comparative Study Group.
    Am J Psychiatry; 2008 Jun 07; 165(6):721-30. PubMed ID: 18281409
    [Abstract] [Full Text] [Related]

  • 47. Modification of cocaine-induced behavioral and neurochemical effects by serotonin1A receptor agonist/antagonist in mice.
    Nakamura S, Ago Y, Hayashi A, Itoh S, Kakuda M, Hashimoto H, Baba A, Matsuda T.
    Synapse; 2006 Dec 01; 60(7):479-84. PubMed ID: 16952156
    [Abstract] [Full Text] [Related]

  • 48. Altered gene expression in the prefrontal cortex of young rats induced by the ADHD drug atomoxetine.
    Lempp T, Toennes SW, Wunder C, Russe OQ, Möser CV, Kynast KL, Freitag CM, Niederberger E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan 10; 40():221-8. PubMed ID: 22960082
    [Abstract] [Full Text] [Related]

  • 49. Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study.
    Nagai T, Kitahara Y, Shiraki A, Hikita T, Taya S, Kaibuchi K, Yamada K.
    Neurosci Lett; 2010 Feb 12; 470(2):134-8. PubMed ID: 20045719
    [Abstract] [Full Text] [Related]

  • 50. Differential increase of extracellular dopamine and serotonin in the 'prefrontal cortex' and striatum of pigeons during working memory.
    Karakuyu D, Herold C, Güntürkün O, Diekamp B.
    Eur J Neurosci; 2007 Oct 12; 26(8):2293-302. PubMed ID: 17908172
    [Abstract] [Full Text] [Related]

  • 51. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.
    Bradshaw SE, Agster KL, Waterhouse BD, McGaughy JA.
    Brain Res; 2016 Jun 15; 1641(Pt B):245-57. PubMed ID: 26774596
    [Abstract] [Full Text] [Related]

  • 52. Tph2 gene deletion enhances amphetamine-induced hypermotility: effect of 5-HT restoration and role of striatal noradrenaline release.
    Carli M, Kostoula C, Sacchetti G, Mainolfi P, Anastasia A, Villani C, Invernizzi RW.
    J Neurochem; 2015 Nov 15; 135(4):674-85. PubMed ID: 26259827
    [Abstract] [Full Text] [Related]

  • 53. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
    Smith A, Cubillo A, Barrett N, Giampietro V, Simmons A, Brammer M, Rubia K.
    Biol Psychiatry; 2013 Oct 15; 74(8):615-22. PubMed ID: 23731741
    [Abstract] [Full Text] [Related]

  • 54. Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats.
    Rowley HL, Kulkarni RS, Gosden J, Brammer RJ, Hackett D, Heal DJ.
    J Psychopharmacol; 2014 Mar 15; 28(3):254-69. PubMed ID: 24327450
    [Abstract] [Full Text] [Related]

  • 55. Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats.
    Ago Y, Umehara M, Higashino K, Hasebe S, Fujita K, Takuma K, Matsuda T.
    Neurochem Res; 2014 May 15; 39(5):825-32. PubMed ID: 24634253
    [Abstract] [Full Text] [Related]

  • 56. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
    Husarova V, Bittsansky M, Ondrejka I, Dobrota D.
    Psychiatry Res; 2014 Apr 30; 222(1-2):75-83. PubMed ID: 24679996
    [Abstract] [Full Text] [Related]

  • 57. Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas.
    Quarta D, Leslie CP, Carletti R, Valerio E, Caberlotto L.
    Neuropharmacology; 2011 Apr 30; 60(2-3):328-35. PubMed ID: 20868698
    [Abstract] [Full Text] [Related]

  • 58. Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.
    Somkuwar SS, Jordan CJ, Kantak KM, Dwoskin LP.
    Neuropsychopharmacology; 2013 Dec 30; 38(13):2588-97. PubMed ID: 23822950
    [Abstract] [Full Text] [Related]

  • 59. Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain.
    Weikop P, Yoshitake T, Kehr J.
    Eur Neuropsychopharmacol; 2007 Oct 30; 17(10):658-71. PubMed ID: 17383162
    [Abstract] [Full Text] [Related]

  • 60. Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice.
    Käenmäki M, Tammimäki A, Myöhänen T, Pakarinen K, Amberg C, Karayiorgou M, Gogos JA, Männistö PT.
    J Neurochem; 2010 Sep 30; 114(6):1745-55. PubMed ID: 20626558
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.